Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

This Is What Whales Are Betting On Moderna

A whale with a lot of money to spend has taken a noticeably bearish stance on Moderna. Looking…

A whale with a lot of money to spend has taken a noticeably bearish stance on Moderna.

Looking at options history for Moderna (NASDAQ:MRNA) we detected 17 strange trades.

If we consider the specifics of each trade, it is accurate to state that 41% of the investors opened trades with bullish expectations and 58% with bearish.

From the overall spotted trades, 7 are puts, for a total amount of $513,939 and 10, calls, for a total amount of $797,370.

What’s The Price Target?

Taking into account the Volume and Open Interest on these contracts, it appears that whales have been targeting a price range from $135.0 to $220.0 for Moderna over the last 3 months.

Volume & Open Interest Development

Looking at the volume and open interest is a powerful move while trading options. This data can help you track the liquidity and interest for Moderna’s options for a given strike price. Below, we can observe the evolution of the volume and open interest of calls and puts, respectively, for all of Moderna’s whale trades within a strike price range from $135.0 to $220.0 in the last 30 days.

Moderna Option Volume And Open Interest Over Last 30 Days

Options Call Chart

Biggest Options Spotted:

Symbol PUT/CALL Trade Type Sentiment Exp. Date Strike Price Total Trade Price Open Interest Volume
MRNA PUT SWEEP NEUTRAL 01/19/24 $220.00 $222.6K 700 30
MRNA CALL SWEEP BEARISH 01/19/24 $155.00 $220.5K 536 0
MRNA CALL TRADE BEARISH 01/17/25 $155.00 $216.0K 72 0
MRNA PUT SWEEP BEARISH 03/24/23 $150.00 $78.1K 212 505
MRNA CALL SWEEP BULLISH 04/21/23 $155.00 $75.3K 908 238

Where Is Moderna Standing Right Now?

  • With a volume of 1,771,149, the price of MRNA is up 0.06% at $151.87.
  • RSI indicators hint that the underlying stock is currently neutral between overbought and oversold.
  • Next earnings are expected to be released in 47 days.

What The Experts Say On Moderna:

  • Deutsche Bank has decided to maintain their Buy rating on Moderna, which currently sits at a price target of $200.
  • RBC Capital downgraded its action to Outperform with a price target of $200
  • SVB Leerink downgraded its action to Underperform with a price target of $93
  • TD Cowen upgraded its action to Outperform with a price target of $180

Options are a riskier asset compared to just trading the stock, but they have higher profit potential. Serious options traders manage this risk by educating themselves daily, scaling in and out of trades, following more than one indicator, and following the markets closely.

If you want to stay updated on the latest options trades for Moderna, Benzinga Pro gives you real-time options trades alerts.

Related Posts